DashboardAll companies
Run this on your own research
7 Apr 2026

Profusa, Inc. fell −34.0%

Why it plunged on 7 Apr 2026: the catalyst, the news around it and the technical picture.

PFSANASDAQHealthcare
Close
1.22
Previous close
1.85
Change
−34.0%
Volume ratio
0.0x
8,458,487 vs 240,302,291

Catalyst

Pattern: Gap down

Why it plunged

No news summary for this move. The closest articles found are listed under sources.

Technical picture

MACD bullishAbove SMA 20
RSI (14)
51.06
SMA 20
0.76
Bollinger lower
0.10
Bollinger upper
1.43
Bollinger middle
0.76
MACD
−0.22
MACD signal
−0.42
MACD histogram
0.20

Sources

5 articles
  1. FDA Sets PDUFA Date for Hansa Biopharma's Imlifidase to December 19 · Uk.Marketscreener · 5 Mar 2026
  2. Fortuna Mining Advances Diamba Sud with Permit Application and Upcoming Resource Estimate - Fortuna Mining (NYSE:FSM) · Benzinga · 10 Feb 2026
  3. Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment · Tipranks · 7 Apr 2026
  4. Teva Pharmaceutical Receives FDA Approval For PONLIMSI As Biosimilar To Prolia, And Application For Biosimilar To Xolair - Teva Pharmaceutical Indus (NYSE:TEVA) · Benzinga · 30 Mar 2026
  5. Insiders commit over $1M as Prospera Energy funds well reactivations · Stocktitan · 9 Mar 2026
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Profusa, Inc. Surged +-34.0% on 2026-04-07 — Analysis | AlphaLenz